Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson’s Disease, Chronic Pain), By End-use, By Region, 2025 - 2030

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson’s Disease, Chronic Pain), By End-use, By Region, 2025 - 2030


Specialized Nutrition Market Growth & Trends

The global specialized nutrition market size is expected to reach USD 154.21 billion by 2030, growing at a CAGR of 7.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness about health and wellness has driven demand for specialized nutrition products. Consumers are becoming more informed about the benefits of customized nutrition for enhancing overall performance and managing age-related health issues. Furthermore, a shift towards preventive health measures has led to greater interest in nutrition that supports specific health needs, such as enhanced athletic performance or managing chronic conditions in the elderly. These trends are expected to drive the market growth.

An increase in the number of ready-to-consume specialized nutrition products available in the market, such as protein bars, meal replacement shakes, and snackable supplements, is expected to drive the market during the forecast period. Furthermore, there is a growing variety of products available, catering to different dietary preferences and requirements, including plant-based, gluten-free, and allergen-free options, thus further expected to augment the growth and demand for the specialized nutrition during the forecast period.

The market for specialized nutrition, encompassing sports and elderly foods, has emerged as a significant segment of the food industry. Sports nutrition, targeted towards athletes and fitness enthusiasts, provides tailored dietary solutions to enhance performance, recovery, and overall well-being. This market segment includes products such as protein powders, sports drinks, energy bars, and supplements that meet the specific nutritional demands of individuals engaged in strenuous physical activity. The increasing popularity of fitness and sports participation drives the growth of the sports nutrition market, as consumers seek specialized products to support their active lifestyles.

On the other hand, elderly foods cater to the unique nutritional requirements of older adults. As individuals age, their dietary needs change, often requiring specialized products that address age-related physiological and metabolic shifts. Elderly foods typically focus on providing essential nutrients, enhancing cognitive function, and supporting bone health. They include products such as fortified foods, nutrient-dense beverages, and supplements designed to address the specific nutritional concerns of seniors. The aging population and growing life expectancies contribute to the increasing demand for elderly foods, making this segment an important area of focus for food manufacturers.

Specialized Nutrition Market Report Highlights
  • The prebiotics & probiotics ingredient segment is expected to grow at a CAGR of 9.0% from 2025 to 2030. Scientific studies have highlighted the benefits of prebiotics and probiotics in managing digestive disorders, improving gut health, overall immune function, and supporting mental health.
  • The application of specialized nutrition in sports is expected to grow at a CAGR of 8.4% from 2025 to 2030. The growing trend towards fitness and active lifestyles has driven increased demand for sports nutrition products. As more people engage in regular physical activity, there is a heightened need for nutrition that supports performance and recovery.
  • The U.S. market for specialized nutrition is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is witnessing significant growth due to increasing consumer interest in customized dietary solutions to address specific health concerns, such as diabetes, obesity, and aging-related issues. Growing awareness about the benefits of functional foods and supplements is driving demand, particularly among older adults and health-conscious millennials.
  • The specialized nutrition industry in Europe is projected to grow at a CAGR of 7.0% from 2025 to 2030. The Europe market is experiencing steady growth, driven by increasing consumer awareness of health and wellness, alongside rising demand for personalized and functional nutrition products.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Neuromodulation Devices Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Government funding for research and development
3.2.1.2. Technological advancements in neuromodulation devices
3.2.1.3. Increasing prevalence of neurological disorders
3.2.1.4. Growing reimbursement coverage
3.2.1.5. Expanding applications
3.2.2. Market Restraint Analysis
3.2.2.1. Complex regulatory framework
3.2.2.2. Surgery-associated risk
3.3. Neuromodulation Devices Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Neuromodulation Devices Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
4.1. Neuromodulation Devices Market: Product Outlook and Key Takeaways
4.2. Neuromodulation Devices Market: Product Movement Analysis
4.3. Neuromodulation Devices Market Estimates & Forecast, by Product (USD Million)
4.4. Spinal Cord Stimulators
4.4.1. Spinal Cord Stimulators Market, 2018 - 2030 (USD Million)
4.5. Deep Brain Stimulators
4.5.1. Deep Brain Stimulators Market, 2018 - 2030 (USD Million)
4.6. Sacral Nerve Stimulators
4.6.1. Sacral Nerve Stimulators Market, 2018 - 2030 (USD Million)
4.7. Vagus Nerve Stimulators
4.7.1. Vagus Nerve Stimulators Market, 2018 - 2030 (USD Million)
4.8. Gastric Electrical Stimulation
4.8.1. Gastric Electrical Stimulation Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Neuromodulation Devices Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
5.1. Neuromodulation Devices Market: Application Outlook and Key Takeaways
5.2. Neuromodulation Devices Market: Application Movement Analysis
5.3. Neuromodulation Devices Market Estimates & Forecast, by Application (USD Million)
5.4. Parkinson’s Disease
5.4.1. Parkinson’s Disease Market, 2018 - 2030 (USD Million)
5.5. Chronic Pain
5.5.1. Chronic Pain Market, 2018 - 2030 (USD Million)
5.6. Epilepsy
5.6.1. Epilepsy Market, 2018 - 2030 (USD Million)
5.7. Migraine
5.7.1. Migraine Market, 2018 - 2030 (USD Million)
5.8. Urinary & Faecal Incontinence
5.8.1. Urinary & Faecal Incontinence Market, 2018 - 2030 (USD Million)
5.9. Tremor
5.9.1. Tremor Market, 2018 - 2030 (USD Million)
5.10. Depression
5.10.1. Depression Market, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Neuromodulation Devices Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
6.1. Neuromodulation Devices Market: End Use Outlook and Key Takeaways
6.2. Neuromodulation Devices Market: End Use Movement Analysis
6.3. Neuromodulation Devices Market Estimates & Forecast, by End Use (USD Million)
6.4. Hospitals & Ambulatory Surgery Centers (ASC)
6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) Market, 2018 - 2030 (USD Million)
6.5. Clinics & Physiotherapy Centers
6.5.1. Clinics & Physiotherapy Centers Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 - 2030 (USD Million
Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Recent Developments & Impact Analysis by Key Market Participants
8.3. Company Market Share Analysis, 2024
8.4. Key Company Profiles
8.4.1. Abbott
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Medtronic
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Boston Scientific Corporation
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Nexstim
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. LivaNova PLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Neuropace Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Nevro Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. electroCore, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Axonics, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Laborie
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings